Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mallolas

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
HIV Clinical Trials|April 30, 2016
Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP SubstudyM Crespo, J Navarro, M Martinez-Rebollar, et al.
AIDS (London, England)|January 11, 2000
Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapyE Martínez, M A García-Viejo, M A Marcos, et al.
Thorax|June 1, 1995
Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDSP Fernandez, A Torres, J M Miro, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 10, 1998
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patientsC Vidal, F García, J M Gatell, et al.
AIDS (London, England)|December 5, 1997
Cytomegalovirus disease in HIV-1-infected patients treated with protease inhibitorsJ Mallolas, J Arrizabalaga, M Loncá, et al.
European Journal of Internal Medicine|September 20, 2011
Clinical presentation of acute coronary syndrome in HIV infected adults: a retrospective analysis of a prospectively collected cohortR Perelló, M Calvo, O Miró, et al.
BMC Infectious Diseases|December 6, 2019
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapyR Perello, A Vergara, E Monclus, et al.
BMC Infectious Diseases|April 21, 2018
Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patientsS Camon, C Quiros, N Saubi, et al.
AIDS (London, England)|August 16, 2001
Lymphoid tissue viral burden and duration of viral suppression in plasmaE Martínez, M Arnedo, V Giner, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2007
Impact of steady-state lopinavir plasma levels on plasma lipids and body composition after 24 weeks of lopinavir/ritonavir-containing therapy free of thymidine analoguesA León, E Martinez, M Sarasa, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
HIV Clinical Trials|April 30, 2016
Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP SubstudyM Crespo, J Navarro, M Martinez-Rebollar, et al.
AIDS (London, England)|January 11, 2000
Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapyE Martínez, M A García-Viejo, M A Marcos, et al.
Thorax|June 1, 1995
Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDSP Fernandez, A Torres, J M Miro, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 10, 1998
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patientsC Vidal, F García, J M Gatell, et al.
AIDS (London, England)|December 5, 1997
Cytomegalovirus disease in HIV-1-infected patients treated with protease inhibitorsJ Mallolas, J Arrizabalaga, M Loncá, et al.
European Journal of Internal Medicine|September 20, 2011
Clinical presentation of acute coronary syndrome in HIV infected adults: a retrospective analysis of a prospectively collected cohortR Perelló, M Calvo, O Miró, et al.
BMC Infectious Diseases|December 6, 2019
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapyR Perello, A Vergara, E Monclus, et al.
BMC Infectious Diseases|April 21, 2018
Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patientsS Camon, C Quiros, N Saubi, et al.
AIDS (London, England)|August 16, 2001
Lymphoid tissue viral burden and duration of viral suppression in plasmaE Martínez, M Arnedo, V Giner, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2007
Impact of steady-state lopinavir plasma levels on plasma lipids and body composition after 24 weeks of lopinavir/ritonavir-containing therapy free of thymidine analoguesA León, E Martinez, M Sarasa, et al.
Pageof 14